LH
Labcorp Holdings Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers): holder breadth 0.0% · share flow +19.5% · net new positions 0.0% — formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | +5 | 56.58M | $15.83B | +9 | −3 |
| Q1 2026 | 155 | +1 | 55.32M | $14.74B | +4 | −4 |
| Q4 2025 | 153 | -1 | 61.82M | $15.50B | +1 | −1 |
| Q3 2025 | 19 | 0 | 33.10M | $9.50B | — | −1 |
| Q2 2025 | 17 | -1 | 30.31M | $7.95B | +1 | −2 |
| Q1 2025 | 15 | +2 | 7.94M | $1.85B | +2 | — |
| Q4 2024 | 13 | 0 | 9.58M | $2.20B | +2 | −2 |
| Q3 2024 | 12 | +1 | 4.32M | $962.67M | +2 | −1 |
| Q2 2024 | 11 | — | 5.93M | $1.21B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 3.70M | — | $849.30M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 2.00M | +2.0% | $458.33M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 2.00M | +2.0% | $458.33M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Citadel Advisors ✦ | 1.43M | +968.7% | $328.02M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 1.43M | +968.7% | $328.02M | 0.3% | ▲ Add | 2 | SEC ↗ |
| 6 | Norges Bank ✦ (passive) | 1.05M | +0.5% | $239.81M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Millennium Management ✦ | 704.77K | +303.2% | $161.62M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | Wellington Management ✦ | 263.53K | -19.4% | $60.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 263.53K | -19.4% | $60.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 263.53K | -19.4% | $60.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 263.53K | -19.4% | $60.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 263.53K | -19.4% | $60.43M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 151.52K | -41.0% | $34.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 151.52K | -41.0% | $34.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 151.52K | -41.0% | $34.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 151.52K | -41.0% | $34.75M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | T. Rowe Price ✦ | 117.84K | -0.3% | $27.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 117.84K | -0.3% | $27.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 55.77K | -9.4% | $12.79M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 20 | Adage Capital Partners ✦ | 42.64K | New | $9.78M | 0.0% | New | 1 | SEC ↗ |
| 21 | Bridgewater Associates ✦ | 36.45K | -75.7% | $8.36M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 25.64K | New | $5.88M | 0.1% | New | 1 | SEC ↗ |
| 23 | Fisher Asset Management ✦ | 2.03K | +62.8% | $466,254 | 0.0% | ▲ Add | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| Adage Capital Partners | $9.78M | 0.0% |
| Gotham Asset Management | $5.88M | 0.1% |
Exited
| Renaissance Technologies | $13.23M | was 0.0% |
| Marshall Wace | $6.24M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1,014 holders, 76.41M shares, $19.36B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Director · 3.00K sh · $954,060
Officer, Director · 4.67K sh · $1.50M
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology